Related Experiment Video
Updated: Mar 24, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
Published on: October 25, 2013
Anti-infectives in Drug Delivery-Overcoming the Gram-Negative Bacterial Cell Envelope
Florian Graef1, Sarah Gordon1, Claus-Michael Lehr2,3
1Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), Helmholtz Center for Infection Research (HZI), Saarbrücken, Germany.
Abstract:
Infectious diseases are becoming a major menace to the state of health worldwide, with difficulties in effective treatment especially of nosocomial infections caused by Gram-negative bacteria being increasingly reported. Inadequate permeation of anti-infectives into or across the Gram-negative bacterial cell envelope, due to its intrinsic barrier function as well as barrier enhancement mediated by resistance mechanisms, can be identified as one of the major reasons for insufficient therapeutic effects. Several in vitro, in silico, and in cellulo models are currently employed to increase the knowledge of anti-infective transport processes into or across the bacterial cell envelope; however, all such models exhibit drawbacks or have limitations with respect to the information they are able to provide. Thus, new approaches which allow for more comprehensive characterization of anti-infective permeation processes (and as such, would be usable as screening methods in early drug discovery and development) are desperately needed. Furthermore, delivery methods or technologies capable of enhancing anti-infective permeation into or across the bacterial cell envelope are required. In this respect, particle-based carrier systems have already been shown to provide the opportunity to overcome compound-related difficulties and allow for targeted delivery. In addition, formulations combining efflux pump inhibitors or antimicrobial peptides with anti-infectives show promise in the restoration of antibiotic activity in resistant bacterial strains. Despite considerable progress in this field however, the design of carriers to specifically enhance transport across the bacterial envelope or to target difficult-to-treat (e.g., intracellular) infections remains an urgently needed area of improvement. What follows is a summary and evaluation of the state of the art of both bacterial permeation models and advanced anti-infective formulation strategies, together with an outlook for future directions in these fields.
Insights
Treating Gram-negative bacterial infections is challenging due to poor drug penetration. New models and advanced delivery systems, like particle carriers, are needed to improve anti-infective efficacy and combat resistance.
Area of Science:
- Microbiology and Infectious Diseases
- Drug Delivery and Nanotechnology
- Bacterial Pathogenesis
Background:
- Gram-negative bacteria pose a significant global health threat, particularly in healthcare settings.
- Ineffective treatment of Gram-negative infections stems from the bacterial cell envelope's barrier properties and resistance mechanisms.
- Current models for studying anti-infective transport across bacterial envelopes have limitations.
Purpose of the Study:
- To review and evaluate current bacterial permeation models and advanced anti-infective formulation strategies.
- To highlight the need for improved methods to characterize anti-infective permeation.
- To identify future directions for enhancing anti-infective delivery and overcoming bacterial resistance.
Main Methods:
- Review of existing in vitro, in silico, and in cellulo models for studying anti-infective permeation.
- Evaluation of advanced anti-infective formulation strategies, including particle-based carriers and combination therapies.
- Analysis of current challenges and limitations in drug delivery across the Gram-negative bacterial envelope.
Main Results:
- Existing models for assessing anti-infective permeation have significant drawbacks.
- Particle-based carrier systems show potential for overcoming drug delivery challenges and enabling targeted delivery.
- Formulations combining efflux pump inhibitors or antimicrobial peptides with anti-infectives can restore antibiotic activity against resistant strains.
Conclusions:
- There is a critical need for novel approaches to comprehensively characterize anti-infective permeation processes.
- Advanced formulation strategies, particularly particle-based carriers, are essential for improving anti-infective efficacy.
- Further research is required to design carriers that enhance transport across bacterial envelopes and target difficult-to-treat infections.
More Related Videos
08:19Generating Transposon Insertion Libraries in Gram-Negative Bacteria for High-Throughput Sequencing
Published on: July 7, 2020
10:24Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii
Published on: April 10, 2020
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Bioavailability Enhancement: Drug Permeability Enhancement
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Bacterial Cell Wall